Clinical Updates & Insights

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

229 Clinical Updates found
Deborah Korenstein
Recently published data from Memorial Sloan Kettering shows that most of the guidelines primary care physicians can turn to for advice about appropriate cancer survivorship care are vague and inconsistent, throwing up barriers to effective post cancer care.
Mohit Chawla, MD, FCCP
Advanced interventional pulmonology techniques are revolutionizing the diagnosis and treatment of lung cancer, often minimizing the need for multiple invasive procedures.
Vivian E. Strong, MD, FACS
Our recent research confirms that total gastrectomy should be considered for all patients with the CDH1 gene mutation that carries a high risk for developing hereditary diffuse gastric cancer.
Anita Kumar, MD, speaks to a patient
There is no established standard therapy for the treatment of mantle cell lymphoma (MCL). Instead, there is a range of treatment options and, to date, there has been a dearth of data to assist in clinical decision-making.
MSK radiology tech
Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms.
MSK breast medical oncologist Shari Goldfarb
Our research shows that most women diagnosed with either breast or gynecologic cancer have concerns about how treatment may affect their sexual and vaginal health. Moreover, they want their healthcare providers to initiate the discussion.
MSK breast cancer patient Elizabeth Shelley
Advances in our understanding of the biology of breast cancer are guiding the development of individualized treatment plans. We outline the clinical case history of young breast cancer patient, Elizabeth Shelley, including our rational for not proceeding with the originally prescribed chemotherapy.
MSK Surgeon Alvin C. Goh, MD
Performing minimally invasive robotic cystectomy and bladder reconstruction in one operation provides a viable alternative to open surgery with less blood loss, decreased pain, diminished wound morbidity, and the potential for faster return of bowel function.
Elizabeth Morris
Recent data from Memorial Sloan Kettering shows that a real-time breast ultrasound exam after second opinion review of outside, static breast ultrasound images led to a change in the initially prescribed management in 32.5 percent of included patients.
MSK lab tests
Active surveillance of prostate cancer is being increasingly utilized for men with low-risk cancer. But some men with potentially life-threatening cancers are being inadvertently enrolled in such programs, driving the need for more accurate decision-making tools such as the 4Kscore test developed at Memorial Sloan Kettering.